Medical Devices Sector to Offer Lucrative Growth Opportunities for Neurodiagnostics Market during the Forecast Period

According to the new report published by Grand View Research, The rising prevalence of neurological disorders, such as stroke, ischemic stroke, epilepsy, migraine, Parkinson’s disease across the US and Canada is expected to drive the growth of this market.

The global neurodiagnostics market was valued at 13.6 billion in 2015 and is expected to reach a value of USD 18.3 billion by 2024, according to a new report by Grand View Research, Inc. Key factors driving the market growth include increasing prevalence of neurological diseases due to demographic changes and growing awareness of their management. In addition, consistent technological modifications coupled with increased preference for novel diagnostic technologies will further fuel the market. The economic burden of neurological diseases is extremely high on society and governments with around 1 billion people suffering globally.



Among all the neuro imaging techniques, computed tomography has the largest market share followed by Magnetic Resonance Imaging (MRI). Computed Tomography (CT) uses ionized radiations for the purpose of creating images, whereas MRI uses radio waves in a magnetic field. Neuroimaging techniques are used to detect brain injuries, developmental malformations in the brain area, vascular irregularities that may lead to stroke, epilepsy, etc.

Biomarkers are an important part of in vitro diagnostics for neurological disorders as their development is targeted at the early disease diagnosis with information about nervous system. Although biomarkers are not commercially available in the market, their use is confined to clinical research settings. For instance, ELISA tests for Tau protein are available in clinical studies of Alzheimer’s disease. In addition, neuroinformatics is a field that studies neuroscience and information technology. This integration allows the storage of neurological data in the form databases. The neuroinformatics market is expected to grow at second highest growth rate during the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/neurodiagnostics-market

Further Key Findings From the Study Suggest:

Increased life expectancy has resulted in increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer’s disease and Parkinson’s disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.
CT and MRI are the most commonly used imaging techniques across the globe, which are mainly used to detect brain abnormalities.
Neurological biomarkers are extremely promising as they provide a direction to the diagnostic studies. Although currently no commercial biomarker is available in the market, an extensive clinical research is happening to find out the perfect combinations of the biomarkers.
North America held the major market share of around 36% in the year 2015 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit highest CAGR of 4% over the forecast period.

View All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Neurodiagnostics market by Technology, and region:

Technology Outlook (Market revenue in USD Million, 2013 - 2024)

Neuroimaging Technologies
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Nuclear Medicine Imaging (PET, SPECT)
Near Infrared Spectroscopic Imaging (NIRS)
Electroencephalography (EEG)
Magnetoencephalography (MEG)
Voxel-based Morphometry (VBM)
In Vitro Diagnostics
Neuroinformatics
Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

North America
S.
Canada
Europe
UK
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East and Africa
South Africa

Browse Press Release of this Report: https://www.grandviewresearch.com/press-release/global-neurodiagnostics-market


Contact Details

Company Name: Grand View Research, Inc
Issued By: Sherry James
Phone: 1-415-349-0058
Address: Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Web: www.grandviewresearch.com
City: San Francisco
State: CA
Zip: 3036
Country: United States
Website: Visit the website

Keywords : Neurodiagnostics Market, Medical Devices Sector,

by Sherry James (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.